Clinical significance of interstitial lung abnormalities and immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer.

Murata, Daiki; Azuma, Koichi; Matama, Goushi; Zaizen, Yoshiaki; Matsuo, Norikazu; Murotani, Kenta; Tokito, Takaaki; Hoshino, Tomoaki

Murata, Daiki; Azuma, Koichi; Matama, Goushi; Zaizen, Yoshiaki; Matsuo, Norikazu; Murotani, Kenta; Tokito, Takaaki; Hoshino, Tomoaki.

Afiliación

Murata D; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.
Azuma K; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.
Matama G; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.
Zaizen Y; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.
Matsuo N; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.
Murotani K; Biostatistics Center, Kurume University School of Medicine, Kurume, Japan.
Tokito T; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.
Hoshino T; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.

Thorac Cancer ; 14(1): 73-80, 2023 01.

Article en En | MEDLINE | ID: mdl-36377039

Asunto(s)

Carcinoma de Pulmón de Células no Pequeñas; Quistes; Enfermedades Pulmonares Intersticiales; Neoplasias Pulmonares; Humanos; Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico; Carcinoma de Pulmón de Células no Pequeñas/complicaciones; Neoplasias Pulmonares/tratamiento farmacológico; Neoplasias Pulmonares/complicaciones; Inhibidores de Puntos de Control Inmunológico/uso terapéutico; Estudios Retrospectivos; Relevancia Clínica; Enfermedades Pulmonares Intersticiales/tratamiento farmacológico; Pulmón; Quistes/complicaciones

Palabras clave

ICI-ILD; ILA; NSCLC; PD-1 inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Pulmonares Intersticiales / Carcinoma de Pulmón de Células no Pequeñas / Quistes / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Thorac Cancer Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google